Ocular Therapeutix Inc (OCUL)
6.18
-0.09
(-1.44%)
USD |
NASDAQ |
May 17, 16:00
6.18
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Shareholders Equity (Quarterly): 407.98M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 407.98M |
December 31, 2023 | 91.13M |
September 30, 2023 | 7.853M |
June 30, 2023 | 3.087M |
March 31, 2023 | 9.711M |
December 31, 2022 | 35.38M |
September 30, 2022 | 46.23M |
June 30, 2022 | 65.80M |
March 31, 2022 | 79.80M |
December 31, 2021 | 88.00M |
September 30, 2021 | 87.34M |
June 30, 2021 | 80.25M |
March 31, 2021 | 83.41M |
December 31, 2020 | 76.10M |
September 30, 2020 | -4.126M |
June 30, 2020 | 5.344M |
March 31, 2020 | -10.66M |
December 31, 2019 | -3.63M |
September 30, 2019 | 11.30M |
June 30, 2019 | 8.258M |
March 31, 2019 | 25.65M |
Date | Value |
---|---|
December 31, 2018 | 35.88M |
September 30, 2018 | 45.52M |
June 30, 2018 | 45.73M |
March 31, 2018 | 49.18M |
December 31, 2017 | 26.15M |
September 30, 2017 | 35.92M |
June 30, 2017 | 48.02M |
March 31, 2017 | 63.90M |
December 31, 2016 | 52.01M |
September 30, 2016 | 62.29M |
June 30, 2016 | 70.45M |
March 31, 2016 | 80.17M |
December 31, 2015 | 89.59M |
September 30, 2015 | 98.81M |
June 30, 2015 | 109.11M |
March 31, 2015 | 52.07M |
December 31, 2014 | 58.70M |
September 30, 2014 | 65.60M |
June 30, 2014 | -69.44M |
March 31, 2014 | 11.15M |
December 31, 2013 | -59.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.66M
Minimum
Mar 2020
407.98M
Maximum
Mar 2024
58.43M
Average
40.80M
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 5.022B |
Assertio Holdings Inc | 134.49M |
CytomX Therapeutics Inc | -31.68M |
EyePoint Pharmaceuticals Inc | 249.93M |
Cormedix Inc | 58.01M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 538.95M |
Total Liabilities (Quarterly) | 130.96M |
Debt to Equity Ratio | 0.1629 |
Current Ratio | 21.39 |
Net Debt Paydown Yield | -0.18% |